510(k) K010177

VISUALINE II (ALSO KNOWN AS SUNLINE) AMPHETAMINE ASSAY by Sun Biomedical Laboratories, Inc. — Product Code DKZ

K010177 is an FDA 510(k) premarket notification submitted by Sun Biomedical Laboratories, Inc. for the device "VISUALINE II (ALSO KNOWN AS SUNLINE) AMPHETAMINE ASSAY". The FDA issued a decision of Substantially Equivalent on May 17, 2001. The device falls under product code DKZ (Enzyme Immunoassay, Amphetamine), a Class II device regulated under 21 CFR 862.3100. Sun Biomedical Laboratories, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 17, 2001
Date Received
January 18, 2001
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Immunoassay, Amphetamine
Device Class
Class II
Regulation Number
862.3100
Review Panel
TX
Submission Type